Pharmacomechanical coupling in vascular smooth muscle cells--an overview.

Abstract

In vascular smooth muscles, neurotransmitters or autacoids produce contraction through activation of Ca2(+)-influx and release of Ca2+ from intracellular store sites. These agonists appear to activate Ca2(+)-influxes in both voltage-dependent and voltage-independent manners. The release of Ca2+ is though to be linked to the action of inositol 1,4,5-trisphosphate. The phosphorylation of myosin light chain may be the mechanism for the Ca2(-+)-induced contraction in smooth muscles. Some agonists only transiently increase cellular Ca2+ and the phosphorylation of myosin, but they produce a sustained contraction in various vascular tissues. Hence, additional high Ca2(+)-sensitive mechanisms are no doubt involved in the contraction of vascular smooth muscle. In the present article, attention will be directed to the mechanisms and agonist-induced contraction in arterial smooth muscle.

Statistics

050'94'97'00'03'06'09'12'15
Citations per Year

54 Citations

Semantic Scholar estimates that this publication has 54 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Itoh1991PharmacomechanicalCI, title={Pharmacomechanical coupling in vascular smooth muscle cells--an overview.}, author={Tomohoro Itoh}, journal={Japanese journal of pharmacology}, year={1991}, volume={55 1}, pages={1-9} }